Literature DB >> 28438877

IT-based Psychosocial Distress Screening in Patients with Sarcoma and Parental Caregivers via Disease-specific Online Social Media Communities.

Florian Pohlig1, Ulrich Lenze2, Heinrich M L Muhlhofer2, Florian W Lenze2,3, Johannes Schauwecker2, Carolin Knebel2, Tanja Zimmermann4, Peter Herschbach5.   

Abstract

BACKGROUND: Psychosocial distress can be frequently observed in patients with sarcoma, depicting a relevant clinical problem. However, prospective data collection on psychosocial distress in patients with rare tumors is often time-consuming. In this context, social media such as Facebook can serve as a potential platform to expand research. The aim of this study was to assess the feasibility of psychosocial distress screening in patients with osteosarcoma and Ewing's sarcoma via social media.
MATERIALS AND METHODS: For this study an online questionnaire including general information and self-assessment distress measurement tools for patients and parents was created. The link to the questionnaire was then posted on the main page of the two largest disease-specific Facebook communities on osteosarcoma and Ewing's sarcoma.
RESULTS: Within 2 months, 28 patients and 58 parents of patients were enrolled. All patients with osteosarcoma and Ewing's sarcoma, as well as the majority of parental caregivers of such patients, showed relevant psychosocial distress levels.
CONCLUSION: Crowdsourcing via disease-specific patient communities on Facebook is feasible and provides great potential for acquisition of medical data of rare diseases. Copyright
© 2017, International Institute of Anticancer Research (Dr. George J. Delinasios), All rights reserved.

Entities:  

Keywords:  Ewing's sarcoma; Facebook; Psychosocial distress; crowdsourcing; osteosarcoma; psycho-oncology

Mesh:

Year:  2017        PMID: 28438877      PMCID: PMC5461459          DOI: 10.21873/invivo.11081

Source DB:  PubMed          Journal:  In Vivo        ISSN: 0258-851X            Impact factor:   2.155


  35 in total

Review 1.  Osteosarcoma: ESMO clinical recommendations for diagnosis, treatment and follow-up.

Authors:  S Bielack; D Carrle; P G Casali
Journal:  Ann Oncol       Date:  2009-05       Impact factor: 32.976

2.  Prevalence of mental health conditions in cancer patients in acute care--a meta-analysis.

Authors:  S Singer; J Das-Munshi; E Brähler
Journal:  Ann Oncol       Date:  2009-11-03       Impact factor: 32.976

3.  New Frontiers in Education: Facebook as a Vehicle for Medical Information Delivery.

Authors:  Carolina Lugo-Fagundo; Madison B Johnson; Rachel Black Thomas; Pamela T Johnson; Elliot K Fishman
Journal:  J Am Coll Radiol       Date:  2016-03       Impact factor: 5.532

4.  [Problems of female cancer patients and their coping behavior].

Authors:  P Herschbach; A M Rosbund; J C Brengelmann
Journal:  Onkologie       Date:  1985-08

5.  Adults with Ewing's sarcoma/primitive neuroectodermal tumor: adverse effect of older age and primary extraosseous disease on outcome.

Authors:  E H Baldini; G D Demetri; C D Fletcher; J Foran; K C Marcus; S Singer
Journal:  Ann Surg       Date:  1999-07       Impact factor: 12.969

Review 6.  The Ewing family of tumors. Ewing's sarcoma and primitive neuroectodermal tumors.

Authors:  H E Grier
Journal:  Pediatr Clin North Am       Date:  1997-08       Impact factor: 3.278

7.  [The role of psycho-oncology in orthopedic tumor centers].

Authors:  U Lenze; C Kirchhoff; K Book; F Pohlig; G Gradl; H Rechl; P Herschbach; R von Eisenhart-Rothe
Journal:  Orthopade       Date:  2012-12       Impact factor: 1.087

Review 8.  The impact of measuring patient-reported outcomes in clinical practice: a systematic review of the literature.

Authors:  J M Valderas; A Kotzeva; M Espallargues; G Guyatt; C E Ferrans; M Y Halyard; D A Revicki; T Symonds; A Parada; J Alonso
Journal:  Qual Life Res       Date:  2008-01-04       Impact factor: 4.147

9.  Bone cancers.

Authors:  H D Dorfman; B Czerniak
Journal:  Cancer       Date:  1995-01-01       Impact factor: 6.860

10.  Osteosarcoma incidence and survival rates from 1973 to 2004: data from the Surveillance, Epidemiology, and End Results Program.

Authors:  Lisa Mirabello; Rebecca J Troisi; Sharon A Savage
Journal:  Cancer       Date:  2009-04-01       Impact factor: 6.860

View more
  4 in total

1.  Standardized Screening and Psycho-oncological Treatment of Orthopedic Cancer Patients.

Authors:  Florian Lenze; Chlodwig Kirchhoff; Florian Pohlig; Carolin Knebel; Hans Rechl; Birgit Marten-Mittag; Peter Herschbach; Rüdiger V Eisenhart-Rothe; Ulrich Lenze
Journal:  In Vivo       Date:  2018 Sep-Oct       Impact factor: 2.155

2.  Opportunities and pitfalls of social media research in rare genetic diseases: a systematic review.

Authors:  Emily G Miller; Amanda L Woodward; Grace Flinchum; Jennifer L Young; Holly K Tabor; Meghan C Halley
Journal:  Genet Med       Date:  2021-07-19       Impact factor: 8.864

3.  The Patient Perspective on the Impact of Tenosynovial Giant Cell Tumors on Daily Living: Crowdsourcing Study on Physical Function and Quality of Life.

Authors:  Monique Josephine Mastboom; Rosa Planje; Michiel Adreanus van de Sande
Journal:  Interact J Med Res       Date:  2018-02-23

4.  The road to successful people-centric research in rare diseases: the web-based case study of the Immunology and Congenital Disorders of Glycosylation questionnaire (ImmunoCDGQ).

Authors:  Rita Francisco; Sandra Brasil; Carlota Pascoal; Jaak Jaeken; Merell Liddle; Paula A Videira; Vanessa Dos Reis Ferreira
Journal:  Orphanet J Rare Dis       Date:  2022-03-24       Impact factor: 4.123

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.